Interleaving programming of subthalamic deep brain stimulation to reduce side effects with good motor outcome in a patient with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 17, Issue 4, 2011, Pages 293-294

  Wojtecki, Lars ^a   Vesper, Jan ^a   Schnitzler, Alfons ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Deep brain stimulation; Interleaving programming; Motor outcome; Parkinson's disease; Side effects; Subthalamic

Indexed keywords

AMANTADINE; APOMORPHINE; CATECHOL METHYLTRANSFERASE INHIBITOR; LEVODOPA; PRAMIPEXOLE; ROTIGOTINE;

ADULT; AMPLITUDE MODULATION; BRAIN DEPTH STIMULATION; CASE REPORT; CATALEPSY; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE DURATION; DISEASE SEVERITY; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG DOSE REDUCTION; DYSARTHRIA; ELECTRIC FIELD; HUMAN; HYPOKINESIA; INFUSION PUMP; LETTER; MOTOR PERFORMANCE; MUSCLE RIGIDITY; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT MOBILITY; PRIORITY JOURNAL; RISK REDUCTION; SUBTHALAMIC NUCLEUS; THERAPY EFFECT; TREATMENT PLANNING; TREMOR; ZONA INCERTA;

DEEP BRAIN STIMULATION; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 79954999121     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.12.005     Document Type: Letter

References (3)

1. Deuschl G., Herzog J., Kleiner-Fisman G., Kubu C., Lozano A.M., Lyons K.E., et al. Deep brain stimulation: postoperative issues. Mov Disord 2006, 21(Suppl. 14):S219-S237.
2. Volkmann J., Moro E., Pahwa R. Basic algorithms for the programming of deep brain stimulation in Parkinson's disease. Mov Disord 2006, 21(Suppl. 14):S284-S289.
3. Moro E., Poon Y.Y., Lozano A.M., Saint-Cyr J.A., Lang A.E. Subthalamic nucleus stimulation: improvements in outcome with reprogramming. Arch Neurol 2006, 63(9):1266-1272.